HSF1 and cancer: In contrast, the percentage of cancer cells in the S+G2M phase was significantly decreased in HSF1 knockdown group than in the control group under HSP90 inhibitor treatment(Fig. 4C), indicating that under HSP90 inhibition the knockdown of HSF1 blocks cancer cells to enter the cell cycle, thereby decrease the proliferation of cancer cells.